Literature DB >> 1391975

Racial differences in cancer of the male breast--15 year experience in the Detroit metropolitan area.

M S Simon1, E McKnight, A Schwartz, S Martino, G M Swanson.   

Abstract

Characteristics of cancer of the male breast were evaluated in a population based review of 244 cases identified retrospectively through the Metropolitan Detroit Cancer Surveillance System (MDCSS) between 1973 and 1987. The mean age at diagnosis was 65 years and median survival time, 44 months. There were no apparent time trends in incidence for either white or black men from 1973 through 1987. Modified radical mastectomy was the most common surgical procedure, while simple and radical mastectomy declined in popularity over time. Cox's proportional hazards regression model was used to test the simultaneous effects of age, race, stage, and treatment on survival. Men older than 65 at diagnosis had a greater risk of dying than men under 65 (RR 1.52, 95% confidence interval, 1.01-2.28). Survival was significantly worse for men who presented at a more advanced stage; regional versus localized (RR 2.19, 95% confidence interval, 1.39-3.45) and remote versus localized (RR 4.31, 95% confidence interval 2.26-8.23). Race had no significant effect on survival in men with breast cancer in the Detroit Metropolitan Area.

Entities:  

Mesh:

Year:  1992        PMID: 1391975     DOI: 10.1007/bf01811964

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  22 in total

1.  Male breast cancer: a clinicopathologic study of 97 cases.

Authors:  K S Heller; P P Rosen; D Schottenfeld; R Ashikari; D W Kinne
Journal:  Ann Surg       Date:  1978-07       Impact factor: 12.969

2.  Incidence of male breast cancer in Scandinavia, 1943-1982.

Authors:  M Ewertz; L Holmberg; S Karjalainen; S Tretli; H O Adami
Journal:  Int J Cancer       Date:  1989-01-15       Impact factor: 7.396

3.  Treatment results in males with breast cancer.

Authors:  R Robison; E D Montague
Journal:  Cancer       Date:  1982-01-15       Impact factor: 6.860

4.  Prognostic factors of carcinoma of the male breast.

Authors:  K Ouriel; M T Lotze; J R Hinshaw
Journal:  Surg Gynecol Obstet       Date:  1984-10

Review 5.  Male breast carcinoma. II. A study of the total material reported to the Swedish Cancer Registry 1958-1967 with respect to treatment, prognostic factors and survival.

Authors:  R Hultborn; S Friberg; K A Hultborn; L E Peterson; I Ragnhult
Journal:  Acta Oncol       Date:  1987       Impact factor: 4.089

6.  Risk factors for male breast cancer.

Authors:  K Mabuchi; D S Bross; I I Kessler
Journal:  J Natl Cancer Inst       Date:  1985-02       Impact factor: 13.506

7.  Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation.

Authors:  B Fisher; C Redmond; E R Fisher; M Bauer; N Wolmark; D L Wickerham; M Deutsch; E Montague; R Margolese; R Foster
Journal:  N Engl J Med       Date:  1985-03-14       Impact factor: 91.245

8.  Male breast cancer in Israel: selected epidemiological aspects.

Authors:  R Steinitz; L Katz; M Ben-Hur
Journal:  Isr J Med Sci       Date:  1981 Sep-Oct

9.  Male breast carcinoma.

Authors:  G R Hodson; L F Urdaneta; A S Al-Jurf; P R Jochimsen
Journal:  Am Surg       Date:  1985-01       Impact factor: 0.688

10.  Male breast carcinoma--a review of 301 cases from the Christie Hospital & Holt Radium Institute, Manchester.

Authors:  G Ribeiro
Journal:  Br J Cancer       Date:  1985-01       Impact factor: 7.640

View more
  3 in total

1.  Male breast cancer: 22 case reports at the National Hospital of Niamey-Niger (West Africa).

Authors:  Sani Rachid; Harouna Yacouba; Nouhou Hassane
Journal:  Pan Afr Med J       Date:  2009-11-16

Review 2.  Lobular carcinoma of the male breast associated with the use of cimetidine.

Authors:  P San Miguel; M Sancho; J L Enriquez; J Fernandez; F Gonzalez-Palacios
Journal:  Virchows Arch       Date:  1997-03       Impact factor: 4.064

3.  The impact of race in male breast cancer treatment and outcome in the United States: a population-based analysis of 4,279 patients.

Authors:  Jacob Y Shin; Lisa A Kachnic; Ariel E Hirsch
Journal:  Int J Breast Cancer       Date:  2014-10-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.